About IDDI
We are an expert clinical data services and high-level strategic consulting contract research organization (CRO), providing agile clinical trials services for pharmaceutical, biotech, and medical device/diagnostic companies.
With a proven track record, IDDI provides expert Biostatistics and eClinical Services to ensure the successful execution of your clinical development program.
Passion. Science. Experience.
A passionate and experienced science-led team, committed to delivering submission-ready clinical data.
Meet Our TeamCommitment to Quality and Precision
“IDDI was of great benefit, particularly with respect to their responsiveness, their commitment to quality and precision, and their ability to meet our very ambitious timelines.”
Jim Taylor, CEO Oraya Therapeutics, Newark, CA, USA
How IDDI Adds Value to Your Clinical Data
Strategic-level consultancy to optimize your clinical development program even in clinical trials with complex settings.
Delivered by talented, forward-thinking and science-led professionals, who will take ownership of your needs.
Over 30 years in business ensuring continuity in your clinical development.
IDDI’s culture is scientifically driven, thanks to its founder and Chief Scientific Officer, Marc Buyse, CEO.
Expert clinical data services (EDC/RTSM/Medical Coding) providing flexible solutions for collection, standardization, analysis, documentation and reporting of your clinical data.
A Project Manager is assigned to every project. Flexibility, responsiveness, proactiveness are skills often mentioned by our customers.
Experienced contract research organization with a solid understanding of the clinical development process and breadth of therapeutic areas expertise.
Thanks to a strong collaborative approach with Academics and Key Opinion Leaders.
Resource Library
Discover our on-demand recorded webinars, podcasts, videos and scientific articles.
Videos ›
Webinars ›
Podcasts ›
Scientific Articles ›
Brochures ›
Fast growing company – Rewarding career. Join us and contribute to the progress of clinical research. An inspiring and exciting career with international and challenging projects is waiting for you!
Join UsSeptember 21, 2021
Biostatistics and SARS-CoV-2: research, policymaking, and communication
Learn on the central role of Biostatistics in the COVID-19 Pandemia, and the multidisciplinary nature of pandemic response LISTEN TO…
View WebinarASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop
Statistics in the Changing Product-Development Environment Accelerated by the Pandemic Marc Buyse, ScD speaker at the plenary session: Statistics in…
Sample Size Re-Estimation as an Adaptive Design
Using the promising-zone approach can salvage an underpowered trial. Sample size Re-estimation (SSRE) is a relatively new concept, but, thanks…
IDDI Sponsor at Gene Therapy for Ophthalmic Disorders Digital Conference
Join IDDI at the 2nd Gene Therapy for Ophthalmic Disorders Digital meeting. It will target the industry’s translational challenges in targeting…
Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints
Vaiva Deltuvaite-Thomas, Research Statistician, IDDI and Prof. Tomasz Burzykowski, VP Research IDDI have just published an article on operational characteristics…
IDDI at Knowledge for Growth 2021
Meet IDDI’s team and visit our exhibition booth (BeCRO Booth #18-19-20) at Knowledge for Growth Conference, taking place on-site on…
Immunotherapy against cancer: Challenge and opportunities
With some of the recently developed drugs showing unprecedented response rates and consistent improvement in overall survival in some indications,…
IDDI Faculty Member at the Global Congress on Prostate Cancer (PROSCA)
IDDI speaker at the PROSCA 2021 Laurence Collette ,PhD presenting on: “How to interpret subgroup analyses? Insights from the statistician”…
IDDI Newsletter – July 2021
IDDI HAS JUST LAUNCHED ITS NEW WEBSITE! We are very excited to launch our brand new website! IDDI is an…
Biostatistics and SARS-CoV-2: research, policymaking, and communication
Learn on the central role of Biostatistics in the COVID-19 Pandemia, and the multidisciplinary nature of pandemic response LISTEN TO…
Webinar: Randomization and the Limits of Precision Oncology
Drug development in oncology is undergoing several changes brought about by precision medicine, which makes it appealing to move efficacy…